Results 191 to 200 of about 73,649 (308)

Multiple Primary Malignancies in Patients With Gastric Cancer: A Retrospective Study in National Cancer Center of China

open access: yesCancer Innovation, Volume 5, Issue 3, June 2026.
This study demonstrates multiple primary malignancies (MPMs) occur in 4.01% of gastric cancer patients and most commonly involve the esophagus, colorectum, and lung. Distinct differences are observed between synchronous and metachronous cases. These findings establish a clinical and epidemiological framework to inform future investigations into MPMs in
Guiling Zhu   +6 more
wiley   +1 more source

Nonmetastatic nasopharyngeal carcinoma: in search of safer therapies. [PDF]

open access: yesLancet Reg Health Am
The Lancet Regional Health-Americas.
europepmc   +1 more source

Real‐World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Objective Metronomic chemotherapy (mCHT) is widely used in the treatment of breast cancer due to its low toxicity and convenience. However, there remain real‐world studies with satisfactory samples focusing on mCHT in advanced breast cancer. Methods Enrolled patients were assigned into capecitabine‐based (X‐based) group and other mCHT group ...
Hanxing Zhou   +6 more
wiley   +1 more source

Exosomal miR‐4644 Targets SPRY3 to Promote Proliferation and Invasion of Pancreatic Cancer

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Tumor‐derived exosomes (TDEs) can carry diverse genetic material that modulates pancreatic cancer (PC) proliferation and invasion. Despite this, the involvement of microRNAs (miRNAs) in TDE‐mediated tumor progression in PC remains inadequately explored. Methods Ultracentrifugation was used to isolate exosomes derived from AsPC‐1 and
Xiangyu Chu   +8 more
wiley   +1 more source

The Prognostic Value of Serum Inflammatory Markers in Nasopharyngeal Carcinoma Patients Treated With Immune Checkpoint Inhibitors: A Multicenter Study

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment of nasopharyngeal carcinoma (NPC), reliable predictive biomarkers need to be further explored. This study aimed to investigate the predictive ability of inflammatory markers for poor prognosis in NPC patients treated with ICIs. Methods In this multicenter
Yang Xu   +12 more
wiley   +1 more source

Prognostic Value and Therapeutic Implications of MRI-Based Negative Lymph Nodes in Nasopharyngeal Carcinoma. [PDF]

open access: yesCancer Med
Lin ZQ   +12 more
europepmc   +1 more source

MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Objective This study aimed to develop and validate an MRI‐based DeltaHabitat radiomics model to predict pathological complete response (pCR) in oral cavity squamous cell carcinoma (OCSCC) patients treated with neoadjuvant chemoimmunotherapy. Methods Patients treated with neoadjuvant chemoimmunotherapy and surgery were retrospectively included ...
Lin Ding   +8 more
wiley   +1 more source

Patterns of regional recurrences after treatment of nasopharyngeal carcinoma. [PDF]

open access: yesRadiat Oncol
Lin Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy